Is Congress harming pharmaceutical research by limiting enforcement of improvement patents?
Robert L. Stoll
Advertisement
Articles by Robert L. Stoll
Advertisement
Latest Updated Articles
- Attacks on Pharmaceutical Improvement Patents
Published: August 21st 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Sanofi Reaches Deals with ADEL for Novel Alzheimer’s Disease Drug, Dren Bio for B-cell Depletion Therapy
2
FDA Approves Enhertu Plus Perjeta as First-Line Therapy for HER2-Positive Metastatic Breast Cancer
3
Lunit and Daiichi Sankyo Form Collaboration to Advance Research and Discovery for AI-Driven Biomarkers and Translational Oncology
4
Pharmaceutical Executive Daily: TrumpRx's Critical Blind Spot
5
